The distribution of neurokinin-1 and neurokinin-2 receptors in human central airways

被引:67
作者
Mapp, CE
Miotto, D
Braccioni, F
Saetta, M
Turato, G
Maestrelli, P
Krause, JE
Karpitskiy, V
Boyd, N
Geppetti, P
Fabbri, LM
机构
[1] Univ Padua, Inst Occupat Med, I-35128 Padua, Italy
[2] Neurogen Inc, Biochem Sect, Branford, CT USA
[3] Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA
[4] Univ Ferrara, Res Ctr Asthma & COPD, I-44100 Ferrara, Italy
[5] Univ Ferrara, Pharmacol Sect, Dept Expt & Clin Med, I-44100 Ferrara, Italy
关键词
D O I
10.1164/ajrccm.161.1.9903137
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
The precise locations of neurokinin (NK)-1 and NK-2 receptors in human airways, and their role in airway inflammatory diseases, have not been carefully examined. To determine the distribution of NK-1 and NK-2 receptors in human central airways, and to determine whether their distribution was different in smokers, we examined surgical specimens from patients undergoing lung resection for limited lung lesions. We mapped NK-1 and NK-2 receptors in four groups of subjects: four asymptomatic nonsmokers, seven asymptomatic smokers, seven symptomatic smokers with normal lung function, and eight symptomatic smokers with chronic airflow limitation. Tissues were immunostained with anti-NK-1- and anti-NK-2-receptor antibodies. Expression of NK-1 and NK-2 receptors was quantified through light microscopy and image analysis. Both NK-1 and NK-2 receptors were found in bronchial glands, bronchial vessels, and bronchial smooth muscle. Although no receptors were observed in the epithelium, receptors were occasionally found in nerves (NK-1) and in inflammatory cells (NK-2) such as T lymphocytes, macrophages, and mast cells. The distribution of both NK-1 and NK-2 receptors was similar in all the tissues examined in the four groups of subjects. These data show that NK-1 and NK-2 receptors are present in human central airways and that their expression is not modified by cigarette smoking.
引用
收藏
页码:207 / 215
页数:9
相关论文
共 34 条
  • [1] INCREASED TACHYKININ RECEPTOR GENE-EXPRESSION IN ASTHMATIC LUNG AND ITS MODULATION BY STEROIDS
    ADCOCK, IM
    PETERS, M
    GELDER, C
    SHIRASAKI, H
    BROWN, CR
    BARNES, PJ
    [J]. JOURNAL OF MOLECULAR ENDOCRINOLOGY, 1993, 11 (01) : 1 - 7
  • [2] EFFECTS ON THE ISOLATED HUMAN BRONCHUS OF SR-48968, A POTENT AND SELECTIVE NONPEPTIDE ANTAGONIST OF THE NEUROKININ-A (NK2) RECEPTORS
    ADVENIER, C
    NALINE, E
    TOTY, L
    BAKDACH, H
    EMONDSALT, X
    VILAIN, P
    BRELIERE, JC
    LEFUR, G
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1992, 146 (05): : 1177 - 1181
  • [3] SUBSTANCE-P (NK1)-RECEPTOR AND NEUROKININ-A (NK2)-RECEPTOR GENE-EXPRESSION IN INFLAMMATORY AIRWAY DISEASES
    BAI, TR
    ZHOU, DY
    WEIR, T
    WALKER, B
    HEGELE, R
    HAYASHI, S
    MCKAY, K
    BONDY, GP
    FONG, T
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 1995, 269 (03) : L309 - L317
  • [4] NK1 receptor antagonist CP-99,994 inhibits cigarette smoke-induced neutrophil and eosinophil adhesion in rat tracheal venules
    Baluk, P
    Bertrand, C
    Geppetti, P
    McDonald, DM
    Nadel, JA
    [J]. EXPERIMENTAL LUNG RESEARCH, 1996, 22 (04) : 409 - 418
  • [5] NEUROPEPTIDES IN THE RESPIRATORY-TRACT .1.
    BARNES, PJ
    BARANIUK, JN
    BELVISI, MG
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 144 (05): : 1187 - 1198
  • [6] BARNES PJ, 1986, LANCET, V1, P242
  • [7] AUTORADIOGRAPHIC MAPPING OF SUBSTANCE-P RECEPTORS IN LUNG
    CASTAIRS, JR
    BARNES, PJ
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 127 (03) : 295 - 296
  • [8] CELLI BR, 1995, AM J RESP CRIT CARE, V152, pS77
  • [9] THE EFFECTS OF TOLUENE DIISOCYANATE AND OF CAPSAICIN ON HUMAN BRONCHIAL SMOOTH-MUSCLE IN-VITRO
    CHITANO, P
    DIBLASI, P
    LUCCHINI, RE
    CALABRO, F
    SAETTA, M
    MAESTRELLI, P
    FABBRI, LM
    MAPP, CE
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY-ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY SECTION, 1994, 270 (2-3): : 167 - 173
  • [10] CHU HW, 1998, AM J RESP CRIT CARE, V157, pA24